Introduction

Organizations in the Pharmaceuticals industry are under increasing pressure to improve ESG and sustainability performance, from internal leadership and employees to external stakeholders such as investors, creditors, policy makers, supply chain partners, and consumers. This presents many challenges depending on your internal competencies and knowledge of material reporting topics and KPIs for the Pharma industry.

SGS has researched the ESG and sustainability reporting activities of the top 100 Pharma companies in the USA & Canada (by revenue). Our team will be presenting those results and noticeable gaps in comparison to what frameworks, standards, and rating agencies are asking from the industry (as delivered in our previous webinar, Pharma & ESG: The Sustainability Mandate).

Once you understand your own unique business drivers and challenges, it crucial to see how you compare against your direct competitors and industry peers. Only then can you focus on what truly matters: leveraging your strengths and overcoming your weaknesses.

Join SGS for our next webinar to learn:

  • ESG and sustainability reporting trends for top 100 Pharma companies
    • Reporting vs. not reporting—and where
    • Most common reporting frameworks and standards
    • Governance structures and board oversight
    • Most common environmental and social topics
    • Most common topics with public targets
    • Seeking 3rd party assurance and what level

Objective

Participants in this webinar will understand the ESG and sustainability reporting trends of the top 100 Pharma companies, gaps compared to external expectations, and what the future might hold for the future of ESG and sustainability reporting in the Pharma industry.

Agenda 

  • Introduction – Who is SGS?
  • What are the ESG and sustainability reporting trends for the top 100 Pharma companies?
    • Reporting vs. not reporting—and where
    • Most common reporting frameworks and standards
    • Governance structures and board oversight
    • Most common environmental and social topics
    • Most common topics with public targets
    • Seeking 3rd party assurance and what level
  • Q&A

Target Audience:

Individuals responsible for ESG and sustainability performance in the Pharma industry.

  • Chief ESG & Sustainability Executives
  • Directors of Investor Relations or Government Affairs
  • ESG & Sustainability Directors or Managers
  • Marketing & Communications
  • Environmental, Facilities, Operations & Supply Chain Managers

Language: English
Cost: No Charge

Can't make a live session? Register now and receive a complimentary recording after the live event. For further information, please contact: KN.NAM.Marketing@sgs.com

_1738767173588